HIV-1 peptide vaccine (microparticulate/monovalent, UBI)

单价微粒多肽疫苗（UBI）

Report date: 2024/06/27 20:00:09

Base Information

Drug NameHIV-1 peptide vaccine (microparticulate/monovalent, UBI)
Drug Alias NameAVEG 018
ClassificationVaccines > Vaccine type > Univalent vaccineVaccines > Development/production technology > Synthetic peptide vaccineVaccines > Application > Prophylactic vaccine +[4] 
Mechanisms of ActionAnti-CD4
TargetsT-cell surface antigen CD4
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUnited Biomedical Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUnited Biomedical IncNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A